XML 111 R97.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-based compensation plans - Activity Related to PCSUs, Restricted Stock Units and Deferred Compensation Plans (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restricted Stock Units (RSUs)      
Number of Shares      
Beginning Balance (in shares) 662,260    
Granted (in shares) 383,708    
Vested (in shares) 0    
Converted (in shares) (231,157)    
Cancelled (in shares) (62,103)    
Dividend equivalents (in shares) 4,488    
Ending Balance (in shares) 757,196 662,260  
Average Grant Date Fair Value per Share      
Beginning Balance, weighted-average grant date fair value (usd per share) $ 54.71    
Granted, weighted-average grant date fair value (usd per share) 52.41    
Converted, weighted-average grant date fair value (usd per share) 55.27    
Cancelled, weighted-average grant date fair value (usd per share) 54.06    
Dividend equivalents, weighted-average grant date fair value (usd per share) 55.42    
Ending Balance, weighted-average grant date fair value (usd per share) $ 53.43 $ 54.71  
Restricted Stock Units (RSUs) | Nonvested      
Number of Shares      
Beginning Balance (in shares) 593,445    
Granted (in shares) 383,708    
Vested (in shares) 234,610    
Converted (in shares)    
Cancelled (in shares) (62,103)    
Dividend equivalents (in shares) 1,176    
Ending Balance (in shares) 681,616 593,445  
Restricted Stock Units (RSUs) | Vested      
Number of Shares      
Beginning Balance (in shares) 68,815    
Granted (in shares) 0    
Vested (in shares) 234,610    
Converted (in shares) (231,157)    
Cancelled (in shares) 0    
Dividend equivalents (in shares) 3,312    
Ending Balance (in shares) 75,580 68,815  
Performance Contingent Restricted Stock Units (PCSUs)      
Number of Shares      
Beginning Balance (in shares) 654,895    
Granted (in shares) 253,176    
Performance adjustments (in shares) (21,184)    
Vested (in shares) 0    
Converted (in shares) (217,966)    
Cancelled (in shares) (35,832)    
Dividend equivalents (in shares) 667    
Ending Balance (in shares) 633,756 654,895  
Average Grant Date Fair Value per Share      
Beginning Balance, weighted-average grant date fair value (usd per share) $ 53.51    
Granted, weighted-average grant date fair value (usd per share) 50.54 $ 55.04 $ 51.94
Performance adjustments, weighted-average grant date fair value (usd per share) 41.05    
Converted, weighted-average grant date fair value (usd per share) 55.48    
Cancelled, weighted-average grant date fair value (usd per share) 52.32    
Dividend equivalents, weighted-average grant date fair value (usd per share) 55.40    
Ending Balance, weighted-average grant date fair value (usd per share) $ 52.13 $ 53.51  
Performance Contingent Restricted Stock Units (PCSUs) | Nonvested      
Number of Shares      
Beginning Balance (in shares) 418,403    
Granted (in shares) 253,176    
Performance adjustments (in shares) (21,184)    
Vested (in shares) 330,888    
Converted (in shares) 0    
Cancelled (in shares) (35,832)    
Dividend equivalents (in shares) 0    
Ending Balance (in shares) 283,675 418,403  
Performance Contingent Restricted Stock Units (PCSUs) | Vested      
Number of Shares      
Beginning Balance (in shares) 236,492    
Granted (in shares) 0    
Performance adjustments (in shares) 0    
Vested (in shares) 330,888    
Converted (in shares) (217,966)    
Cancelled (in shares) 0    
Dividend equivalents (in shares) 667    
Ending Balance (in shares) 350,081 236,492  
Deferred Compensation Plans      
Number of Shares      
Beginning Balance (in shares) 324,602    
Deferred (in shares) 34,113    
Converted (in shares) (8,541)    
Dividend equivalents (in shares) 11,249    
Ending Balance (in shares) 361,423 324,602